Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda

Clinical trial NCT00489658 · TERMINATED

Trial details

NCT number: NCT00489658
Sponsor: Epicentre
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Trypanosomiasis, African

Start date: 2002-10-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.